Warttig SL, Forshaw MJ, South J, White AK. New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4). J Health Psychol. 2013 Dec;18(12):1617-28. doi: 10.1177/1359105313508346
Woods MS, Kiri S, Ling CS, McCrink L, Zimovetz E, Hass B. A systematic review of economic evidence in hepatitis c: methods used in recent economic evaluations. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A579.
Woods MS, Kiri S, Ling CS, McCrink L, Zimovetz E, Hass B. A systematic review of economic evidence in hepatitis c: an overview of cost, utility, and cost-effectiveness data. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A349.
Ling CS, Weisgerber-Kriegl U, Njue AI, Heyes A, Kaye J. The effect of positive margins on outcomes in breast cancer. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A394.
Rycroft C, Fernandez M, Copley-Merriman K. Systematic literature reviews at the heart of health technology assessment: a comparison across markets. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. [abstract] Value Health. 2013 Nov; 16(7):A481.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013 Sep 17;6:327-38.
Copley-Merriman K, Olanrewaju B, Hogue S. The temporal relationship between NSAIDS and risk of gastrointestinal, cardiovascular, and renal events: a systematic review. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2, 2013. [abstract] Value Health. 2013 May; 16(3):A110.
Copley-Merriman C, Olanrewaju B, Hogue S. Systematic literature review of the temporal relationship between nsaid use and gastrointestinal, cardiovascular, or renal events. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A110.
Mordin M, Hogue S, Barrows S, van Amerongen D. Safe and effective versus reasonable and necessary: is the deck stacked against medical devices? Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 May; 16(3):246.
Mordin M, Copley-Merriman C, Mauskopf J, Sweeney C, Bhattacharyya S, Farup C, Beach W, Higgins L, McIntyre L. Surgical innovation: do we need a more balanced framework for evidence? Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 3, 2013. [abstract] Value Health. 2013 May; 16(3):A247.
McIntyre LF, Beach WR, Higgins LD, Mordin MM, Mauskopf J, Sweeney CT, Copley-Merriman C. Evidence-based medicine, appropriate-use criteria, and sports medicine: how best to develop meaningful treatment guidelines. Arthroscopy. 2013 Mar 18;29(7):1224-9.
Bartis D, Csongei V, Weich A, Kiss E, Barko S, Kovacs T, Avdicevic M, D'Souza VK, Rapp J, Kvell K, Jakab L, Nyitrai M, Molnar TF, Thickett DR, Laszlo T, Pongracz JE. Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinoma. PLoS One. 2013;8(3):e57393. doi: 10.1371/journal.pone.0057393
Warttig S, Elliott N. Partially updating a guideline to improve its implementation. Presented at the G-I-N Conference; August 2013. San Francisco, CA. [abstract] BMJ Qual Saf. 2013; 22(Suppl 1):A32. doi: 10.1136/bmjqs-2013-002293.93
Johnson M, Millar L. Primum non nocere în primul rând sâ nu faci râu; recomandări de prevenire a infecţiilor asociate îngrijirilor medicale. In: Daniel Săuca, editors. Caiete silvane. Zalău: Romania. Carole Hallam & Ramona Marincaş; 2013. p.237-49.
Johnson M, Gildea (Millar) L. Audit and supervision. In: Daniel Sauca, editors. First do no harm - recommendations for the prevention of healthcare associated infections. Zalău: Romania. Caiete Silvane Publishing House; 2013. p.237-49.
Xu J, Evans J, Coon C, Copley-Merriman K, Su Y. Measuring patient-reported outcomes in advanced gastric cancer. Ecancermedicalscience. 2013;7:351. doi: 10.3332/ecancer.2013.351.
Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C. Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions. Clinicoecon Outcomes Res. 2013 Jan 1;5:69-85.
Leidy NK, Jonas D, Silberman C, Heyes AE. What role do symptoms play in health-related quality of life? Poster presented at the 8th Annual Conference of the International Society for Quality of Life Research; November 2001. Amsterdam, The Netherlands.
Jonas D, Leidy NK, Silberman C, Margolis MK, Heyes AE. Cognitive factors in symptom assessment: are we asking too much? Poster presented at the 8th Annual Conference of the International Society for Quality of Life Research; November 2001. Amsterdam, The Netherlands.
Sorensen SV, Chambers M, Heyes AE. An economic model for the pharmacological management of advanced non-small cell lung cancer in the US. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2001. Cannes, France. [abstract] Value Health. 2001 Sep; 4(6):403.
Njue AI, Feng X-P, Prichard RK. Ivermectin resistance and the glutamate-gated chloride channels in the cattle nematode cooperia oncophora. Poster presented at the 18th International Conference of the World Association for the Advancement of Veterinary Parasitology; August 2001.
Buchner DA, Graboys TB, Johnson K, Mordin MM, Goodman L, Partsch DS, Goss TF. Development and validation of the ITG Health-Related Quality-of- Life Short-Form measure for use in patients with coronary artery disease. Integrated Therapeutics Group. Clin Cardiol. 2001 Aug;24(8):556-63.
Yang J, Bogerd HP, Wang PJ, Page DC, Cullen BR. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell. 2001 Aug;8(2):397-406.
Shah S, Sesti AM, Chopra T, McLaughlin-Miley C, Copley-Merriman K. Quality of life terminology documented in package inserts. Mapi Quality of Life Newsletter. 2001 Jul;27:1-3.
Njue AI, Prichard RK. Ivermectin resistance in cooperia oncophora and beta-tubulin. Poster presented at the 46th Annual Meeting of the American Association of Veterinary Parasitologists; July 2001.
Anderson H, Espinosa E, Lofts F, Meehan M, Hutchinson G, Price N, Heyes AE. Evaluation of the Chemotherapy Patient Monitor: an interactive tool for facilitating communication between patients and oncologists during the cancer consultation. Eur J Cancer Care (Engl). 2001 Jun;10(2):115-23.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy - Lung (FACT-L): analysis of ECOG 5592 data. Poster presented at the 7th Central European Lung Cancer Conference; June 2001. Prague, Czech Republic. [abstract] Lung Cancer. 2001 May; 32(Suppl 1):52.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the functional assessment of cancer therapy - lung (FACT-L): analysis of ecog 5592 data. Poster presented at the 37th Annual Meeting of the American Society of Clinical Oncology; May 2001. San Francisco, CA.
Leidy NK, Jonas D, Margolis MK, Heyes AE, Jones K, Silberman C. On health-related quality of life, symptoms and the complementary nature of two patient-reported outcomes. Presented at the Drug Information Association Symposium of Contributed Papers on Quality of Life Evaluation; March 2001. Hilton Head, SC.
Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Bonomi P, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy (lung) (FACT-L): analysis of ECOG 5592 data. Lung Cancer. 2001;373-6.